Cedar Gate’s latest analysis shows 13% increase from 2021-2023, but AI model predicts over half of commercially insured women likely to skip mammograms
GREENWICH, CT – As Breast Cancer Awareness Month begins, Cedar Gate Technologies has released new data showing a rise in breast cancer screening rates among commercially insured women. According to Cedar Gate’s National Healthcare Benchmark Database, 53.3% of women received their recommended screening mammogram between 2022 and 2023. This is up from 47.3% in the prior two-year period, an increase of nearly 13%. But almost half of women are still missing out on these critical screenings.
The most recent data is consistent with Cedar Gate’s predictive AI model, which identified that approximately 52% of women due for a mammogram in the coming year are unlikely to get it. This could leave millions of women at risk of missing an early detection opportunity.
“Our data shows that more women are getting mammograms, but there is still a concerning potential for gaps in preventive care,” said David B. Snow, Jr., Chairman and CEO of Cedar Gate. “Providers, payers, and employers need to understand how trends could impact their own patient and member populations to increase the rate of necessary mammograms. Early detection remains the most effective way to improve breast cancer outcomes. Our predictive model enables healthcare organizations to identify women at risk of missing these critical screenings and target their outreach to improve care.”
The analysis evaluated nearly 3.4 million women in Cedar Gate’s National Healthcare Benchmark Database, which includes anonymized data for approximately 15 million member lives. The AI model examines multiple data points and assigns a probability score on whether the person is unlikely to get a mammogram based on U.S. Preventive Services Task Force (USPSTF) guidelines. These guidelines recommend biennial screenings for women between the ages of 40 and 75 who are at average risk for breast cancer. Of the women analyzed, almost 1.75 million were flagged as unlikely to get a mammogram.
The average age of women with breast cancer as a primary diagnosis in Cedar Gate’s database of commercially insured members is 58 years – four years younger than the national median age of 62 for the entire population, which includes Medicare and Medicaid patients. By starting regular mammogram screenings at 40, women and their doctors may detect early signs of cancer sooner, which can lead to more treatment options and better outcomes.
According to 2024 estimates, there will be 310,720 new cases of invasive breast cancer among women in the United States, excluding recurrences. Additionally, there will be 56,500 new cases of ductal carcinoma in situ (DCIS), a non-invasive or pre-invasive form of breast cancer, and 42,250 breast cancer-related deaths. The Centers for Disease Control and Prevention (CDC) advocates for regular mammogram screenings as one of the most effective ways to catch breast cancer early.
About Cedar Gate
Cedar Gate enables payers, providers, employers, and service administrators to excel at value-based care with a unified technology and services platform delivering analytics, care, and payment technology on a single data management foundation. From primary care attribution, to bundled payments, to capitation, Cedar Gate is improving clinical, financial, and operational outcomes for every payment model in all lines of business.
Media Contact:
Gina Ford, Chief Marketing Officer
gina.ford@cedargate.com
